TOMÍŠKOVÁ, Marcela, Jana SKŘIČKOVÁ a Irena VAŠUTOVÁ. Erlotinib (Tarceva) in patients with advanced non-small lung cancer (NSCLC)-The single institution experience. Journal of Thoracic Oncology. Geneva, 2008, roč. 3, č. 4, s. 78-80. ISSN 1556-0864. |
Další formáty:
BibTeX
LaTeX
RIS
@article{766348, author = {Tomíšková, Marcela and Skřičková, Jana and Vašutová, Irena}, article_location = {Geneva}, article_number = {4}, keywords = {non-small cell lung cancer; advanced cancer; treatmetment; erlotinib}, language = {eng}, issn = {1556-0864}, journal = {Journal of Thoracic Oncology}, title = {Erlotinib (Tarceva) in patients with advanced non-small lung cancer (NSCLC)-The single institution experience}, volume = {3}, year = {2008} }
TY - JOUR ID - 766348 AU - Tomíšková, Marcela - Skřičková, Jana - Vašutová, Irena PY - 2008 TI - Erlotinib (Tarceva) in patients with advanced non-small lung cancer (NSCLC)-The single institution experience JF - Journal of Thoracic Oncology VL - 3 IS - 4 SP - 78 EP - 78 SN - 15560864 KW - non-small cell lung cancer KW - advanced cancer KW - treatmetment KW - erlotinib N2 - A single-instution experience is presented of Erlotinib (Tarceva) used to treat patients with advanced non-small lung cancer (NSCLC). ER -
TOMÍŠKOVÁ, Marcela, Jana SKŘIČKOVÁ a Irena VAŠUTOVÁ. Erlotinib (Tarceva) in patients with advanced non-small lung cancer (NSCLC)-The single institution experience. \textit{Journal of Thoracic Oncology}. Geneva, 2008, roč.~3, č.~4, s.~78-80. ISSN~1556-0864.
|